4//SEC Filing
Sabus Steve M 4
Accession 0001562180-22-008056
CIK 0001395937other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 4:41 PM ET
Size
5.7 KB
Accession
0001562180-22-008056
Insider Transaction Report
Form 4
Sabus Steve M
Chief Commercial Officer
Transactions
- Award
Stock Options (Right to buy)
2022-12-05$25.44/sh+220,000$5,596,800→ 220,000 totalExercise: $25.44Exp: 2032-12-05→ Common Stock (220,000 underlying)
Footnotes (1)
- [F1]Twenty five percent (25%) of the total number of shares underlying the option shall vest on December 5, 2023, and one-thirty-sixth (1/36th) of the remaining shares underlying the option shall vest monthly thereafter on the last day of each month, subject to the reporting person's continuous service on the relevant vesting dates.
Documents
Issuer
Syndax Pharmaceuticals Inc
CIK 0001395937
Entity typeother
Related Parties
1- filerCIK 0001930884
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 4:41 PM ET
- Size
- 5.7 KB